Your browser doesn't support javascript.
loading
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases.
Ingwersen, Viktoria; Hofmann, Jörg; Muche, Marion; Le Coutre, Philipp; Schneider, Thomas; Leng, Corinna; Burmeister, Thomas; Maschmeyer, Georg; Keller, Ulrich; Schwartz, Stefan.
Afiliación
  • Ingwersen V; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hofmann J; Department of Virology, Labor Berlin, Charité-Vivantes GmbH, and Institute of Virology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité, Berlin, Germany.
  • Muche M; Department of Gastroenterology, Infectious Diseases, and Rheumatology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Le Coutre P; Department of Hematology, Oncology and Tumor Immunology (Campus Mitte), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schneider T; Department of Gastroenterology, Infectious Diseases, and Rheumatology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Leng C; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Burmeister T; Department of Hematology, Oncology and Tumor Immunology (Campus Virchow-Klinikum), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Maschmeyer G; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Keller U; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schwartz S; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Oncol Res Treat ; 46(7-8): 296-302, 2023.
Article en En | MEDLINE | ID: mdl-37311423
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis E / Hepatitis E / Fallo Hepático Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis E / Hepatitis E / Fallo Hepático Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Alemania